Jonathan I. Silverberg, MD, PhD, MPH, FAAD: Patient Counseling in Atopic Dermatitis
Dr. Silverberg discusses how to safely counsel patients when deciding between topical versus oral JAK inhibitors for the treatment of atopic dermatitis.
Peter Lio, MD, FAAD: Sustainable Improvements for Patients with Atopic Dermatitis
Dr. Lio discusses the effects of topical ruxolitinib in his patients with atopic dermatitis, and how he incorporates this treatment into his practice.
Adam Friedman, MD, FAAD: Matching Patients to the Right Treatments for Atopic Dermatitis
Dr. Friedman discusses how to evaluate patients with atopic dermatitis to match them with their best treatment as well as the importance of keeping a detailed patient history in order to improve ease of access to the most effective medications.
Raj Chovatiya, MD, PhD: Itch in Atopic Dermatitis
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses how to distinguish when to use topical versus oral therapy in patients with atopic dermatitis.
Raj Chovatiya, MD, PhD: Explaining the Mechanisms and Advantages of JAK Inhibitors
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses the newly available JAK inhibitors for use in a variety of dermatological conditions. Dr. Chovatiya reviews how JAK inhibitors work differently from other agents to reduce inflammation and the benefits that they can have for certain patient populations.